Figure 8From: Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumorPoint mutations identified in 7-10 clones of full-length c-kit from (A) TR1, (B) TR2, and (C) TR3 sublines. Mutations were commonly identified in functional domains of the KIT receptor.Back to article page